Sallemi-Boudawara T

No ORCID on file · 1 paper in corpus

2026

A Novel BRCA1 Pathogenic Variant in Tunisian Patient With High Grade Ovarian Cancer: Favorable Therapeutic Response to Olaparib.

Cancer reports (Hoboken, N.J.) ·doi:10.1002/cnr2.70658

BackgroundOvarian cancer is one of the leading causes of death from gynecological cancer worldwide. Genetic mutations in genes involved in key cellular functions such as BRCA1/2 play a central role in tumorigenesis and have major implicatio…